Impact of Pharmacovigilance and Evaluation Activities-A regulatory Perspective

被引：0
|
作者：
Mouchantaf, R. [1 ]
Comarova, N. [2 ]
Bouterfa, F. [2 ]
机构：
[1] Hlth Canada, Ottawa, ON, Canada
[2] Univ Montreal, Montreal, PQ, Canada
来源：
DRUG SAFETY | 2017年 / 40卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
6
引用
收藏
页码：940 / 941
页数：2
相关论文
共 50 条
  • [1] Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability
    Pinheiro, Luis Correia
    Kurz, Xavier
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (12) : 1308 - 1310
  • [2] Measuring the impact of pharmacovigilance activities, challenging but important
    van Hunsel, Florence
    Gardarsdottir, Helga
    de Boer, Anthonius
    Kant, Agnes
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (10) : 2235 - 2237
  • [3] Issues with regulatory pharmacovigilance in East European countries: The industry perspective
    Hanzl-Dujmovic, Ivana
    Sulic-Milisic, Zrinka
    Staresinic-Sernhorst, Ivana
    [J]. TOXICOLOGY LETTERS, 2007, 168 (03) : 228 - 235
  • [4] Unintended impact of pharmacovigilance regulatory interventions: A systematic review
    Lasys, Tomas
    Santa-Ana-Tellez, Yared
    Siiskonen, Satu J.
    Groenwold, Rolf H. H.
    Gardarsdottir, Helga
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (12) : 3491 - 3502
  • [5] Tabulation and analysis of pharmacovigilance data using the medical dictionary for regulatory activities
    Brown, EG
    Douglas, S
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2000, 9 (06) : 479 - 489
  • [6] How to Measure the Impact of Pharmacovigilance Activities on Public Health?
    Gardarsdottir, Helga
    Kant, Agnes
    De Bruin, Marie Louise
    Hallgren, Christine E.
    Dal Pan, Gerald
    Way, Dominic
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 31 - 31
  • [7] Adapting the DIST-M Model for Designing Experimental Activities-A Theoretical Discussion from an Interdisciplinary Perspective
    Lippiello, Stefania
    Boscolo, Alessandra
    [J]. EDUCATION SCIENCES, 2024, 14 (05):
  • [8] Pharmacovigilance in perspective
    Meyboom, RHB
    Egberts, ACG
    Gribnau, FWJ
    Hekster, YA
    [J]. DRUG SAFETY, 1999, 21 (06) : 429 - 447
  • [9] Pharmacovigilance in Perspective
    Ronald H. B. Meyboom
    Antoine C. G. Egberts
    Frank W. J. Gribnau
    Yechiel A. Hekster
    [J]. Drug Safety, 1999, 21 : 429 - 447
  • [10] REMOTE LABORATORY ACTIVITIES-A REQUIRED CHANGE IN MODERN EDUCATION
    Silea, I.
    Nanu, S.
    [J]. MANAGEMENT OF TECHNOLOGICAL CHANGES, VOL 1, 2009, : 721 - 724
12345